Hereditary Angioedema in Sweden : a National Project

Abstract

Picture of C1-inhibitor on the cover made by NGL Viewer published in:AS Rose, AR Bradley, Y Valasatava, JM Duarte, A Prlić and PW Rose. Web-based molecular graphics for large complexes.

Cost-Effectiveness of Prophylactic Medications for the Treatment of Hereditary Angioedema Due to C1 Inhibitor Deficiency: A Real-World U.S. Perspective

“…A comparison between the EQ-5D and an angioedema-specific quality of life instrument revealed multiple differences that could have a significant effect on the analysis. 12 Angioedema-specific, as well as HAE-specific, quality of life instruments have been developed and validated but were not used for this analysis. 13,14 A greater concern is the relatively modest improvement in QALY assigned to patients treated with prophylactic medications in this model.…”